You are here

CDC Admits Teens Vaccinated With Pfizer or Moderna at Higher Risk of Heart Inflammation

CDC Admits Teens Vaccinated With Pfizer or Moderna at Higher Risk of Heart Inflammation --In guidance quietly updated June 1, the Centers for Disease Control and Prevention said there is a higher-than-expected number of cases of myocarditis among young teens after the second dose of an mRNA COVID vaccine. | 10 June 2021 | As CNN reported Wednesday, the Centers for Disease Control and Prevention's (CDC) advisory committee now acknowledges a higher-than-expected number of cases of heart inflammation among 16- to 24-year-olds who recently received a second dose of the Pfizer and Moderna COVID vaccines. Based on a May 24 report from the CDC's Advisory Committee on Immunization Practices (ACIP) COVID-19 Vaccine Safety Technical Work Group (VaST), the CDC on June 1 updated its website with the following language: "Data from VAERS [Vaccine Adverse Events Reporting System] show that in the 30-day window following dose 2 mRNA COVID-19 vaccination, there was a higher number of observed than expected myocarditis/pericarditis cases in 16–24-year-olds."